Rheumatoid Arthritis Pharmaceutical and Healthcare Analysis Information

Pune, India, 14th March 2018: WiseGuyReports announced addition of new report, titled “Rheumatoid Arthritis (RA) - Dynamic Market Forecast to 2025”.

Pune , India - March 14, 2018 /MarketersMedia/ —

Rheumatoid Arthritis (RA) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the RA space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3054186-rheumatoid-arthritis-ra-dynamic-market-forecast-to-2025

Key events covered in the Dynamic Market Forecast include -
- Regulatory filings
- Approval decisions
- Pricing changes
- Patent litigation
- Clinical trial data announcements
- Clinical trial failures
- Clinical trial timeline updates

Components of the slide deck include -
- Timeline of market-impacting events
- Key clinical trial landscape updates
- Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
- Overview of updates to the forecast model based on anticipated future impact of events
- Forward-looking events calendar listing expected key updates to the RA competitive space through June 2018

Reasons to buy
- Recent Regulatory Events
- Recent Commercial Events
- Recent Clinical Events
- Market Dynamics Shifts Towards Biosimilars in the RA Setting
- Discontinuation of J&J’s Sirukumab for RA Creates Opportunity for Other IL-6 Inhibitors
- Increased Competition Among the Oral JAK Inhibitors in the RA Setting

Table of Content: Key Points
1. Dynamic Market Forecast Overview 5
1.1 Related Reports 6
1.2 Upcoming Related Reports 7
2. Executive Summary 8
2.1 Key Updates to RA Market Dynamics 9
2.1 Key Events in Update 10-12
2.2 Clinical Trial Landscape Updates 13
2.3 Pipeline Landscape Updates 14
2.4 Market Insight on Key Events 15
3. Event 1: Market Dynamics Shift Towards Biosimilars 16
3.1 Key Updates to Biosimilar Market Dynamics 17
3.2 Enbrel Biosimilars 18
3.3 Humira Biosimilars 19
3.4 Remicade Biosimilars 20
3.5 Rituxan Biosimilars 21
3.6 What Do Physicians Think? 22
3.7 Summary/Trends 23
3.8 Sources 24
4. Event 2: Discontinuation of Sirukumab Creates Opportunity for Other IL-6 Inhibitors 25
4.1 Key Updates to the Anti-IL-6 Market Dynamics 26
4.2 J&J, sirukumab 27
4.3 Regeneron/Sanofi, Kevzara (sarilumab) 28
4.4 What Do Physicians Think? 29
4.5 Summary/Trends 30
4.6 Sources 31
5. Event 3: Competition Among the Oral JAK Inhibitors 32
5.1 Key Updates to the JAK Inhibitor Market Dynamics 33
5.2 Eli Lilly, Olumiant (baricitinib) 34-35
5.3 AbbVie, upadacitinib 36
5.4 What Do Physicians Think? 37
5.5 Summary/Trends 38
5.6 Sources 39
6. Events Calendar 40
6.1 Key Events Expected to Occur H1 2018 41

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3054186-rheumatoid-arthritis-ra-dynamic-market-forecast-to-2025

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Address: Office No. 528, Amanora Chambers
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/rheumatoid-arthritis-pharmaceutical-and-healthcare-analysis-information/314312

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 314312

More News From Sports - In The Headline

Thomas reaches semifinals and closes in on No. 1

Mar 24, 2018

AUSTIN, Texas — Justin Thomas won two matches Saturday to reach the semifinals of the Dell Technologies Match Play. One more and he gets to No. 1 in the world. Thomas made quick work of Si Woo Kim in the morning, and then trailed for the first time all week against Kyle Stanley — just not for long. Thomas won three straight holes to start the back nine, made a 6-foot par putt to stay in control and closed out Stanley, 2-and-1. Dustin Johnson didn't win a match this week and will not get any world ranking points. That means...

D-backs tab lefty Corbin for opening day start vs Rockies

Mar 24, 2018

SCOTTSDALE, Ariz. — Left-hander Patrick Corbin has been chosen to start for the Arizona Diamondbacks on opening day. Manager Torey Lovullo made the announcement Saturday. He'll make his first opening day start Thursday night when the Diamondbacks host Colorado — Arizona beat the Rockies last year in the NL wild-card game. Corbin was 14-13 with a 4.03 ERA in 32 starts last season. "I'm just excited. I'm honored to go out there. I feel well prepared and ready to go. I got all my work in that I needed to this spring," Corbin said. The opportunity for Corbin arose from...

Bluebloods Kansas, Duke square off with Final Four at stake

Mar 24, 2018

OMAHA, Neb. — In a tournament defined by unpredictability, there will finally be a regional final that makes sense. No. 1 Kansas and No. 2 Duke will square off in the Midwest final Sunday for the last spot in the Final Four — and the stakes are huge even by Elite Eight standards. Mike Krzyzewski is looking to break UCLA legend John Wooden's record of 12 Final Four appearances. Kansas coach Bill Self, who recently joined Krzyzewski and Wooden in the Naismith Hall of Fame, is hoping to snap a two-year losing streak in regional finals and a 2-7 personal...

Red Sox ace Sale hit by liner, expects to be OK for opener

Mar 24, 2018

FORT MYERS, Fla. — This was not the sight the Boston Red Sox envisioned in Chris Sale's final spring training tuneup: Their ace crumpled on the ground, knocked off the mound by a line drive. Sale quickly got up, flexed his leg a few times and walked off the field under his own power Saturday. The AL East champions called it a bruised left hip, and Sale said the injury wasn't serious and wouldn't jeopardize his opening day start Thursday at Tampa Bay. "I don't see anything lingering from this," Sale said. "Looked a lot worse than it really is."...

Curry out at least 3 weeks but could be ready for playoffs

Mar 24, 2018

OAKLAND, Calif. — Stephen Curry will miss at least three weeks with a sprained left knee, meaning the Golden State Warriors will be without their do-everything point guard and second-leading scorer for the rest of the regular season. Curry could be back at the start of the playoffs next month if all goes well in rehabbing his latest injury. An MRI on Saturday showed a Grade 2 sprain of his medial collateral ligament and the team said Curry would be re-evaluated in three weeks — that would be April 14 and a possible Game 1 of the playoffs for Golden...

Sign up now!

About Us

In The Headline sought to bring professionalism back into journalism, bringing you only the most exclusive and the most impactive news from all over the globe.

Contact us: sales[at]intheheadline.com